Literature DB >> 31484030

Complex Task Performance Assessment (CTPA) and Functional Cognition in People With Parkinson's Disease.

Alison Davis1, Timothy J Wolf2, Erin R Foster3.   

Abstract

OBJECTIVE: The objective of this study was to determine how Parkinson's disease (PD) affects functional cognition as assessed by the Complex Task Performance Assessment (CTPA) and to examine the associations of CTPA performance with other indicators of executive function in people with PD.
METHOD: Volunteers with PD without dementia (n = 20) and community control participants (n = 19) completed neuropsychological testing, patient-reported outcome measures, and the CTPA.
RESULTS: There were no group differences for CTPA performance accuracy; however, the PD group took longer to complete the CTPA than did the control group. In the PD group, inefficient CTPA performance correlated with poorer cognitive flexibility and worse reported everyday shifting and task monitoring.
CONCLUSION: Decreased executive function, namely cognitive flexibility and attentional control, may impair functional cognition in people with PD. Future studies with larger, more diverse samples are warranted to determine the discriminant validity and sensitivity of the CTPA. Use of performance-based assessments such as the CTPA may increase the understanding of functional cognition in people with PD.
Copyright © 2019 by the American Occupational Therapy Association, Inc.

Entities:  

Mesh:

Year:  2019        PMID: 31484030      PMCID: PMC6813512          DOI: 10.5014/ajot.2019.031492

Source DB:  PubMed          Journal:  Am J Occup Ther        ISSN: 0272-9490


  31 in total

Review 1.  The ecological validity of neuropsychological tests: a review of the literature on everyday cognitive skills.

Authors:  Naomi Chaytor; Maureen Schmitter-Edgecombe
Journal:  Neuropsychol Rev       Date:  2003-12       Impact factor: 7.444

2.  The Dysexecutive Questionnaire advanced: item and test score characteristics, 4-factor solution, and severity classification.

Authors:  Sebastian Bodenburg; Nina Dopslaff
Journal:  J Nerv Ment Dis       Date:  2008-01       Impact factor: 2.254

3.  Executive dysfunction immediately after mild stroke.

Authors:  Timothy J Wolf; Amy R Barbee; Desiree White
Journal:  OTJR (Thorofare N J)       Date:  2011

4.  The ecological validity of tests of executive function.

Authors:  P W Burgess; N Alderman; J Evans; H Emslie; B A Wilson
Journal:  J Int Neuropsychol Soc       Date:  1998-11       Impact factor: 2.892

5.  Cognitive profile of patients with newly diagnosed Parkinson disease.

Authors:  Dino Muslimovic; Bart Post; Johannes D Speelman; Ben Schmand
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Authors:  J C Dalrymple-Alford; M R MacAskill; C T Nakas; L Livingston; C Graham; G P Crucian; T R Melzer; J Kirwan; R Keenan; S Wells; R J Porter; R Watts; T J Anderson
Journal:  Neurology       Date:  2010-11-09       Impact factor: 9.910

8.  Cognition assessment using the NIH Toolbox.

Authors:  Sandra Weintraub; Sureyya S Dikmen; Robert K Heaton; David S Tulsky; Philip D Zelazo; Patricia J Bauer; Noelle E Carlozzi; Jerry Slotkin; David Blitz; Kathleen Wallner-Allen; Nathan A Fox; Jennifer L Beaumont; Dan Mungas; Cindy J Nowinski; Jennifer Richler; Joanne A Deocampo; Jacob E Anderson; Jennifer J Manly; Beth Borosh; Richard Havlik; Kevin Conway; Emmeline Edwards; Lisa Freund; Jonathan W King; Claudia Moy; Ellen Witt; Richard C Gershon
Journal:  Neurology       Date:  2013-03-12       Impact factor: 9.910

9.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Authors:  Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J Van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

10.  Executive functioning in daily life in Parkinson's disease: initiative, planning and multi-task performance.

Authors:  Janneke Koerts; Marije Van Beilen; Oliver Tucha; Klaus L Leenders; Wiebo H Brouwer
Journal:  PLoS One       Date:  2011-12-20       Impact factor: 3.240

View more
  5 in total

1.  The Weekly Calendar Planning Activity to Assess Functional Cognition in Parkinson Disease.

Authors:  Erin R Foster; Lisa Carson; Jill Jonas; Eunyoung Kang; Tasha Doty; Joan Toglia
Journal:  OTJR (Thorofare N J)       Date:  2022-06-17

Review 2.  Benefits of Tango Therapy in Alleviating the Motor and Non-Motor Symptoms of Parkinson's Disease Patients-A Narrative Review.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Lavinia Florenta Muja; Silviu Docu Axelerad; Dana Simona Chita; Corina Elena Frecus; Cristina Maria Mihai
Journal:  Brain Sci       Date:  2022-03-27

3.  Effects of the Sn100 kVp Tube Voltage Mode on the Radiation Dose and Image Quality of Dual-Source Computed Tomography Pulmonary Angiography.

Authors:  Wei-Guo Zhang; Jia-Ping Liu; Xiu-Qin Jia; Ji-Yang Zhang; Xiang-Nan Li; Qi Yang
Journal:  Int J Gen Med       Date:  2021-03-25

4.  Cognitive Correlates of Instrumental Activities of Daily Living Performance in Parkinson Disease Without Dementia.

Authors:  Erin R Foster; Tasha Doty
Journal:  Arch Rehabil Res Clin Transl       Date:  2021-07-03

5.  Virtual Reality Functional Capacity Assessment Tool (VRFCAT-SL) in Parkinson's Disease.

Authors:  Travis H Turner; Alexandra Atkins; Richard S E Keefe
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.